• 13 January 2010
  • News
  • By Jahanara Parveen

'India has vibrant biotech, pharmaceutial sectors'

"India has vibrant biotech, pharmaceutial sectors"

-Carl-Johan Ivarsson, president, Qlucore

Carl-Johan Ivarsson

The Swedish company Qlucore was founded in early 2007 and the first product released was the ‘Qlucore Gene Expression Explorer'. The bioinformatics software developer has recently entered the Indian market by signing an agreement with JH BIO Innovations, a specialist Indian distribution company that caters to major pharmaceutical companies, research institutes, and universities in India.

Qlucore has received a warm welcome from the Indian market with many companies downloading trial versions of its data analysis software. Qlucore’s latest software, Qlucore Omics Explorer, has been developed for the life science, agricultural and biotech industry. With its highly intuitive user interface, Qlucore Omics Explorer allows researchers to shorten analysis time and add more creativity to research, thanks to the product’s instant response and statistical analysis capabilities.

In an exclusive interview with BioSpectrum, Carl-Johan Ivarsson, president, Qlucore shares more insights.

Can you tell us about Qlucore Omics Explorer and its applications?

Qlucore Omics Explorer is an enhanced data analysis tool that has been developed for the life science and biotech industries. It allows scientists and biologists to explore different hypotheses and alternative scenarios within seconds. The software is therefore invaluable for unveiling important new discoveries, as it allows the actual researchers, the people with the most biological insight, to study the data and to look for patterns and structures, without the help of statistics or computer expert. The product can be used on any multivariate data, including data from gene expression, protein array, DNA methylation and proteomics experiments.

Who funded the product’s development?

Qlucore started as a collaborative research project at Lund University, Sweden, supported by researchers at the departments of mathematics and clinical genetics, in order to address the vast amount of high-dimensional data generated with microarray gene expression analysis. Today, Qlucore remains as a privately-owned company that is committed to achieving this same goal through a dedicated program of product development.

Can you elaborate on Qlucore’s growth plan?

Qlucore currently has customers in eight countries, and we are doubling our sales each year. We expect to sustain this rate
of growth for the next few years.

What is the company’s strategy for growth?

The first step is to create a broader awareness of Qlucore. This can be achieved by working closely with our distributors, agents and other strategic partners in selected countries.

Why is India an important market for Qlucore?

India has vibrant and fast-growing biotech and pharmaceutical sectors. As such, India is currently educating a lot of researchers in these and other related areas, and the Qlucore software will play an important role in their research.

Which are the other Asian regions your products are marketed?

China will be the next big step, and we are already speaking to a number of distributors and agents in this area.

Who are your major clients?

Many well-known research institutions are currently using our software, including the National Cancer Institute in the US, King’s College London in the UK, France’s National Health Institute (INSERM), as well as leading universities in both Sweden and Germany.

What will be the main areas of focus for Qlucore?

We typically focus on data that is derived from life sciences industry, but future possibilities could include virtually any project where the amount of data being produced is very large, such as complex financial applications.

Jahanara Parveen in Bangalore

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box


GST: Boon or Bane for Healthcare?

Send this article by email